Image Source: Unsplash

Summary

• Benitec Biopharma shows strong technical indicators with 100% buy signals, a 127.84+ Weighted Alpha, and a 190.67% gain in the last year.
• The stock is above its 20, 50, and 100-day moving averages, with 11 new highs and a 42.86% increase in the last month.
• Wall Street analysts have issued 7 strong buy opinions with price targets between $17 and $25.43, indicating a potential 75% gain.
• Despite strong technicals, Barchart highlights the stock's volatility and recommends a disciplined approach with diversification and regular stop-loss reevaluation.

The Chart of the Day belongs to the biopharmceutical company Benitec Biopharma (BNTC). I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart feature to review the charts for consistent price appreciation. Since the Trend Seeker signaled a buy on 3/3 the stock gained 16.67%.

BNTC Price vs Daily Moving Averages:

(Click on image to enlarge)

BNTC (Barchart)

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. Benitec Biopharma Inc. was incorporated in 1995 and is headquartered in Hayward, California. 

Barchart's Opinion Trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 20 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com website when you read this report.

Barchart Technical Indicators:

• 100% technical buy signals
• 127.84+ Weighted Alpha
• 190.67% gain in the last year
• Trend Seeker buy signal
• Above its 20, 50 and 100 day moving averages
• 11 new highs and up 42.86% in the last month
• Relative Strength Index 68.43%
• Technical support level at $13.54
• Recently traded at $14.49 with 50 day moving average of $11.41

Fundamental Factors:

• Market Cap $311 million
• Analysts have not given firm Revenue and Earnings estimates

Analysts and Investor Sentiment -- I don't buy stocks because everyone else is buying but I do realize that if major firms and investors are dumping a stock it's hard to make money swimming against the tide:

• Wall Street analysts issued 7 strong buy opinions on the stock with price targets between $17 and $#% with a consensus of $25.43 or a 75% gain
• CFRAs MarketScope rates the stock a hold
• MorningStar thinks the stock is 30% over valued
• There are 12 investor following the stock on Motley fool and 3 think it will beat the market and 9 think it won't
• 2,770 investors monitor the stock on Seeking Alpha

More By This Author:

Pavella - Undiscovered Biotechnology Stock
Xeris Biopharma - Possibly The Best Pharma Stock
Orla Is Golden